Loading clinical trials...

Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2/3NCT00221195

Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors

The objective of this study is to assess whether prophylactic therapy with an activated prothrombin complex concentrate (FEIBA)will result in a significant reduction in the number of bleeds in patient...

Lead sponsor: Tulane University School of Medicine•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

UNKNOWNPhase 2

rFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors

NCT01105546 · Hemophilia A With Inhibitors

TERMINATEDNA

International Immune Tolerance Study

NCT00212472 · Hemophilia A With Inhibitors

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 2, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2/PHASE3

Enrollment34

Start dateJun 2003

Last updatedMar 2, 2020

Condition

Hemophilia A With Inhibitors

Locations shown

Tulane University School of Medicine

New Orleans, Louisiana

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 2, 2020Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions